NYSE:TMOLife Sciences
How Investors May Respond To Thermo Fisher Scientific (TMO) Expanding Access To Parkinson’s Proteomic Data
Thermo Fisher Scientific announced it has completed large-scale Olink Explore HT proteomic analysis on about 5,500 samples from The Michael J. Fox Foundation’s Parkinson’s Precision Medicine Initiative, with the data now accessible through PPMI’s global research repository.
This project creates a substantial proteomics resource that can help researchers investigate protein-level signals of Parkinson’s progression, patient differences, and potential biomarkers when combined with PPMI’s...